enVVeno Medical Corporation
NVNO
$10.32
$0.323.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.85M | -3.74M | -4.54M | -6.69M | -4.50M |
| Total Depreciation and Amortization | 124.00K | 117.00K | 120.00K | 130.00K | 122.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 514.00K | 716.00K | 727.00K | 1.52M | 845.00K |
| Change in Net Operating Assets | -27.00K | -540.00K | -700.00K | 1.33M | -482.00K |
| Cash from Operations | -3.24M | -3.44M | -4.39M | -3.72M | -4.02M |
| Capital Expenditure | -- | 0.00 | 0.00 | -5.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.77M | 4.18M | 3.65M | 2.83M | 5.20M |
| Cash from Investing | 2.77M | 4.18M | 3.65M | 2.82M | 5.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 782.00K | 241.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 782.00K | 241.00K | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -468.00K | 1.52M | -500.00K | -893.00K | 1.18M |